You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

beta-lactam antibiotics

Showing 1 - 25 of 5,773
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Beta-lactam Target Non-attainment Risk Score in Adult ICU

Not yet recruiting
  • Infection, Bacterial
  • +4 more
    • (no location specified)
    Sep 13, 2022

    Surgical Site Infection, Beta-lactam Allergy Trial (cephalosporin, Second tier antibiotic (Vancomycin))

    Not yet recruiting
    • Surgical Site Infection
    • Beta-lactam Allergy
    • (no location specified)
    Feb 25, 2022

    Determining Optimal Beta-lactam Plasma Concentrations Through

    Recruiting
    • Beta-lactam Antibiotics
    • +10 more
    • The study is observational.
    • Geneva, Switzerland
      Geneva University Hospitals
    May 25, 2021

    Healthy Volunteers Trial in London (Phenoxymethyl Penicillin, Microneedle array)

    Completed
    Has Results
    • Healthy Volunteers
    • Phenoxymethyl Penicillin
    • Microneedle array
    • London, United Kingdom
      NIHR Imperial CRF
    Dec 3, 2020

    Cross-allergies Between Cefazolin and Amoxicillin With Skin

    Recruiting
    • Allergic Reaction
    • Beta Lactam Adverse Reaction
      • Paris, France
        Groupe Hospitalier Paris Saint-Joseph
      Nov 7, 2022

      Machine Learning Model for Beta-Lactam Drugs Related Acute

      Active, not recruiting
      • Acute Kidney Injury
      • Beta-Lactam Antibiotic Toxicity (Diagnosis)
      • Beta-Lactam Drugs
      • Jinan, Shandong, China
        Xiao Li，MD
      Sep 8, 2022

      Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation Trial (Beta-lactam antibiotic, Aminoglycoside)

      Not yet recruiting
      • Cystic Fibrosis
      • Cystic Fibrosis Pulmonary Exacerbation
      • (no location specified)
      Sep 16, 2022

      Beta-lactam Pharmacokinetics in Secondary Care

      Completed
      Has Results
      • Pharmacokinetics
      • +2 more
      • Beta-lactam antibiotic
      • London, United Kingdom
        Hammersmith Hospital
      Aug 4, 2021

      Sepsis Trial (prolonged intravenous infusion of ß-lactams Antibiotics)

      Not yet recruiting
      • Sepsis
      • prolonged intravenous infusion of β-lactams Antibiotics
      • (no location specified)
      Aug 22, 2021

      Beta-lactam Therapeutic Drug Monitoring in Singapore

      Recruiting
      • Infection, Bacterial
      • Beta-lactam Therapeutic Drug Monitoring
      • Singapore, Singapore
        Singapore General Hospital
      Apr 9, 2021

      Adjunctive Clindamycin Versus Linezolid for ß-lactam Treated

      Active, not recruiting
      • Streptococcal Sepsis
      • +5 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center (primary center co
      Nov 8, 2023

      Pneumonia Trial in Gainesville (Cefepime, Meropenem, or Piperacillin/Tazobactam)

      Recruiting
      • Pneumonia
      • Cefepime, Meropenem, or Piperacillin/Tazobactam
      • Gainesville, Florida
        University of Florida
      Feb 24, 2022

      Beta-lactam Therapeutic Drug Monitoring Programs in Critically

      Active, not recruiting
      • Sepsis
      • Critical Illness
        • Gainesville, Florida
        • +2 more
        Feb 15, 2022

        Sepsis Trial in France (continuous pivotal ßL-AB, intermittent pivotal ßL-AB, AG infusion most 1 dose)

        Not yet recruiting
        • Sepsis
        • continuous pivotal βL-AB
        • +3 more
        • Amiens, France
        • +23 more
        Feb 1, 2023

        Febrile Neutropenia Trial in Hospitalet de Llobregat (Piperacillin-Tazobactam 4 g-0.5 g, Cefepime 2000 mg, Meropenem 1000 mg)

        Unknown status
        • Febrile Neutropenia
        • Piperacillin-Tazobactam 4 g-0.5 g
        • +2 more
        • Hospitalet de Llobregat, Barcelona, Spain
          Hospital Duran i Reynals
        Feb 11, 2021

        Infections Trial in Shanghai (SZEY-2108 for injetion, Placebo)

        Recruiting
        • Infections
        • SZEY-2108 for injetion
        • Placebo
        • Shanghai, Shanghai, China
          Huashan Hospital Fudan University
        Sep 24, 2023

        Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia Trial in Israel (Piperacillin / Tazobactam

        Recruiting
        • Beta Lactam Resistant Bacterial Infection
        • +2 more
        • Haifa, Israel
        • +3 more
        Jul 25, 2022

        Elderly Infection, Frailty, Frail Elderly Syndrome Trial in Ghent (Blood sampling, Sputum sample, Hemoculture)

        Recruiting
        • Elderly Infection
        • +3 more
        • Blood sampling
        • +3 more
        • Ghent, Belgium
          University Hospital Ghent
        Jan 21, 2022

        Sepsis Trial in Worldwide (Continuous infusion, Intermittent infusion)

        Recruiting
        • Sepsis
        • Continuous infusion
        • Intermittent infusion
        • Bankstown, New South Wales, Australia
        • +105 more
        Sep 26, 2021

        Infections Trial in Ghent (device, diagnostic test, other)

        Not yet recruiting
        • Infections
        • Prediction of plasma concentration of piperacillin-tazobactam or meropenem
        • +2 more
        • Ghent, Belgium
          University Hospital, Ghent
        Sep 4, 2023

        Bacterial Infections Trial in Adelaide (QPX2015, Placebo oral capsule)

        Completed
        • Bacterial Infections
        • Adelaide, South Australia, Australia
          CMAX
        Oct 6, 2022

        COPD Exacerbation Acute Trial in H?i Phòng (Beta-Lactams, Fluoroquinolone)

        Completed
        • COPD Exacerbation Acute
        • Hải Phòng, Vietnam
          Haiphong International Hospital
        May 4, 2021

        Drug Hypersensitivity Trial in Montpellier (simplified drug provocation test)

        Completed
        • Drug Hypersensitivity
        • simplified drug provocation test
        • Montpellier, France
          University hospital of Montpellier
        Dec 30, 2021

        Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia Trial in Canada, Israel

        Recruiting
        • Beta Lactam Resistant Bacterial Infection
        • +2 more
        • Montreal, Quebec, Canada
        • +7 more
        Jul 25, 2022

        Buruli Ulcer Trial in Allada, Lalo, Pobè (Standard [RC8]: rifampicin plus clarithromycin (RC) therapy for 8 weeks.,

        Recruiting
        • Buruli Ulcer
        • Standard [RC8]: rifampicin plus clarithromycin (RC) therapy for 8 weeks.
        • Investigational [RCA4]: standard (RC) plus amoxicillin/clavulanate (A) for 4 weeks.
        • Allada, Benin
        • +2 more
        Dec 22, 2021